SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

CVS Health Corp. – ‘10-K’ for 12/31/23 – ‘EX-32.1’

On:  Wednesday, 2/7/24, at 6:52am ET   ·   For:  12/31/23   ·   Accession #:  64803-24-7   ·   File #:  1-01011

Previous ‘10-K’:  ‘10-K’ on 2/8/23 for 12/31/22   ·   Latest ‘10-K’:  This Filing   ·   38 References:   

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size

 2/07/24  CVS Health Corp.                  10-K       12/31/23  166:28M

Annual Report   —   Form 10-K   —   SEA’34

Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-K        Annual Report                                       HTML   5.22M 
 2: EX-4.29     Instrument Defining the Rights of Security Holders  HTML     57K 
 3: EX-10.22    Material Contract                                   HTML    238K 
 4: EX-10.45    Material Contract                                   HTML     72K 
 5: EX-10.47    Material Contract                                   HTML     62K 
 6: EX-10.53    Material Contract                                   HTML     99K 
 7: EX-10.54    Material Contract                                   HTML    118K 
 8: EX-21.1     Subsidiaries List                                   HTML    182K 
 9: EX-23.1     Consent of Expert or Counsel                        HTML     43K 
14: EX-97.1     Clawback Policy re: Recovery of Erroneously         HTML     52K 
                Awarded Compensation                                             
10: EX-31.1     Certification -- §302 - SOA'02                      HTML     47K 
11: EX-31.2     Certification -- §302 - SOA'02                      HTML     47K 
12: EX-32.1     Certification -- §906 - SOA'02                      HTML     44K 
13: EX-32.2     Certification -- §906 - SOA'02                      HTML     44K 
20: R1          Cover Page                                          HTML    109K 
21: R2          Audit Information                                   HTML     48K 
22: R3          Consolidated Statements of Operations               HTML    162K 
23: R4          Consolidated Statements of Comprehensive Income     HTML     86K 
24: R5          Consolidated Balance Sheets                         HTML    198K 
25: R6          Consolidated Balance Sheets (Parenthetical)         HTML     65K 
26: R7          Consolidated Statements of Cash Flows               HTML    163K 
27: R8          Consolidated Statements of Cash Flows               HTML     44K 
                (Parenthetical)                                                  
28: R9          Consolidated Statements of Shareholders' Equity     HTML    128K 
29: R10         Consolidated Statements of Shareholders' Equity     HTML     49K 
                (Parentheticals)                                                 
30: R11         Significant Accounting Policies                     HTML    427K 
31: R12         Acquisitions, Divestitures and Asset Sales          HTML    114K 
32: R13         Restructuring Program                               HTML     51K 
33: R14         Investments                                         HTML    342K 
34: R15         Fair Value                                          HTML    236K 
35: R16         Goodwill and Other Intangibles                      HTML    103K 
36: R17         Leases                                              HTML    192K 
37: R18         Health Care Costs Payable                           HTML     95K 
38: R19         Other Insurance Liabilities and Separate Accounts   HTML    176K 
39: R20         Borrowings and Credit Agreements                    HTML    128K 
40: R21         Pension Plans and Other Postretirement Benefits     HTML    206K 
41: R22         Income Taxes                                        HTML    111K 
42: R23         Stock Incentive Plans                               HTML    123K 
43: R24         Shareholders' Equity                                HTML     71K 
44: R25         Other Comprehensive Income (Loss)                   HTML    102K 
45: R26         Earnings Per Share                                  HTML     62K 
46: R27         Reinsurance                                         HTML     75K 
47: R28         Commitments and Contingencies                       HTML     96K 
48: R29         Segment Reporting                                   HTML    200K 
49: R30         Pay vs Performance Disclosure                       HTML     55K 
50: R31         Insider Trading Arrangements                        HTML     49K 
51: R32         Significant Accounting Policies (Policies)          HTML    261K 
52: R33         Significant Accounting Policies (Tables)            HTML    310K 
53: R34         Acquisitions, Divestitures and Asset Sales          HTML    105K 
                (Tables)                                                         
54: R35         Restructuring Program (Tables)                      HTML     48K 
55: R36         Investments (Tables)                                HTML    350K 
56: R37         Fair Value (Tables)                                 HTML    245K 
57: R38         Goodwill and Other Intangibles (Tables)             HTML    105K 
58: R39         Leases (Tables)                                     HTML    134K 
59: R40         Health Care Costs Payable (Tables)                  HTML     97K 
60: R41         Other Insurance Liabilities and Separate Accounts   HTML    207K 
                (Tables)                                                         
61: R42         Borrowings and Credit Agreements (Tables)           HTML    120K 
62: R43         Pension Plans and Other Postretirement Benefits     HTML    222K 
                (Tables)                                                         
63: R44         Income Taxes (Tables)                               HTML    112K 
64: R45         Stock Incentive Plans (Tables)                      HTML    124K 
65: R46         Shareholders' Equity (Tables)                       HTML     64K 
66: R47         Other Comprehensive Income (Loss) (Tables)          HTML    102K 
67: R48         Earnings Per Share (Tables)                         HTML     61K 
68: R49         Reinsurance (Tables)                                HTML     74K 
69: R50         Segment Reporting (Tables)                          HTML    195K 
70: R51         Significant Accounting Policies - Narrative         HTML    173K 
                (Details)                                                        
71: R52         Significant Accounting Policies - Cash and Cash     HTML     54K 
                Equivalents, Restricted Cash and Cash Equivalents                
                (Details)                                                        
72: R53         Significant Accounting Policies - Accounts          HTML     61K 
                Receivable (Details)                                             
73: R54         Significant Accounting Policies - Deferred          HTML     53K 
                Acquisition Costs (Details)                                      
74: R55         Significant Accounting Policies - Property and      HTML     66K 
                Equipment (Details)                                              
75: R56         Significant Accounting Policies - Disaggregation    HTML    114K 
                of Revenue (Details)                                             
76: R57         Significant Accounting Policies - Receivables and   HTML     48K 
                Contract Balances (Details)                                      
77: R58         Significant Accounting Policies - Contract          HTML     53K 
                Balances (Details)                                               
78: R59         Significant Accounting Policies - Variable          HTML     88K 
                Interest Entities (Details)                                      
79: R60         Significant Accounting Policies - New Accounting    HTML     83K 
                Pronouncements Recently Adopted (Details)                        
80: R61         Significant Accounting Policies - Changes in        HTML     84K 
                Balances of Long-duration Insurance Liabilities                  
                (Details)                                                        
81: R62         Significant Accounting Policies - Adjustments       HTML    231K 
                Resulting From Applying New Accounting Standard                  
                (Details)                                                        
82: R63         Acquisitions, Divestitures and Asset Sales -        HTML    125K 
                Narrative (Details)                                              
83: R64         Acquisitions, Divestitures and Asset Sales -        HTML     66K 
                Schedule of Fair Value of Consideration                          
                Transferred (Details)                                            
84: R65         Acquisitions, Divestitures and Asset Sales -        HTML    105K 
                Schedule of Estimated Fair Values of Assets                      
                Acquired and Liabilities Assumed (Details)                       
85: R66         Acquisitions, Divestitures and Asset Sales -        HTML     67K 
                Summary of the Valuation of Goodwill Allocated to                
                Business Segments (Details)                                      
86: R67         Acquisitions, Divestitures and Asset Sales -        HTML     64K 
                Summary of Fair Values and Weighted Average Useful               
                Lives for Intangible Assets Acquired (Details)                   
87: R68         Restructuring Program - Narrative (Details)         HTML     51K 
88: R69         Restructuring Program - Change in Severance and     HTML     49K 
                Employee-related Restructuring Charge Liability                  
                (Details)                                                        
89: R70         Investments - Total Investments Schedule (Details)  HTML     62K 
90: R71         Investments - Narrative (Details)                   HTML     57K 
91: R72         Investments - Debt Securities (Details)             HTML     96K 
92: R73         Investments - Debt Securities by Maturity           HTML     86K 
                (Details)                                                        
93: R74         Investments - Unrealized Loss Position (Details)    HTML    119K 
94: R75         Investments - Unrealized Loss Position Maturities   HTML    106K 
                (Details)                                                        
95: R76         Investments - Mortgage Loans (Details)              HTML     50K 
96: R77         Investments - Mortgage Loans Credit Ratings         HTML     92K 
                Indicator (Details)                                              
97: R78         Investments - Mortgage Loan Principal Repayments    HTML     56K 
                (Details)                                                        
98: R79         Investments - Net Investment Income (Details)       HTML     67K 
99: R80         Investments - Realized Gains (Details)              HTML     50K 
100: R81         Fair Value - Measurement on a Recurring Basis       HTML    125K  
                (Details)                                                        
101: R82         Fair Value - Changes in Level 3 Financial Assets    HTML     95K  
                (Details)                                                        
102: R83         Fair Value - Narrative (Details)                    HTML     56K  
103: R84         Fair Value - Gross Transfers Into (Out of) Level 3  HTML     54K  
                (Details)                                                        
104: R85         Fair Value - Carrying Value and Fair Value          HTML     74K  
                Classified by Level (Details)                                    
105: R86         Fair Value - Separate Accounts Fair Value           HTML     81K  
                (Details)                                                        
106: R87         Goodwill and Other Intangibles - Goodwill           HTML     68K  
                (Details)                                                        
107: R88         Goodwill and Other Intangibles - Narrative          HTML     61K  
                (Details)                                                        
108: R89         Goodwill and Other Intangibles - Intangible Assets  HTML     79K  
                (Details)                                                        
109: R90         Goodwill and Other Intangibles - Future             HTML     54K  
                Amortization Expense (Details)                                   
110: R91         Leases - Narrative (Details)                        HTML     80K  
111: R92         Leases - Summary of the Components of Net Lease     HTML     62K  
                Cost (Details)                                                   
112: R93         Leases - Supplemental Cash Flow Information         HTML     58K  
                (Details)                                                        
113: R94         Leases - Supplemental Balance Sheet Information     HTML     89K  
                (Details)                                                        
114: R95         Leases - Maturities of Operating and Finance Lease  HTML    104K  
                Liabilities (Details)                                            
115: R96         Health Care Costs Payable - Incurred and Paid       HTML     59K  
                Health Care Claims Development (Details)                         
116: R97         Health Care Costs Payable - Narrative (Details)     HTML     49K  
117: R98         Health Care Costs Payable - Liability for Unpaid    HTML     59K  
                Claims and Claims Adjustment Expense (Details)                   
118: R99         Health Care Costs Payable - Components of Change    HTML     96K  
                in Health Care Costs Payable (Details)                           
119: R100        Other Insurance Liabilities and Separate Accounts   HTML    122K  
                - Changes in Liability for Future Policy Benefits                
                (Details)                                                        
120: R101        Other Insurance Liabilities and Separate Accounts   HTML     52K  
                - Undiscounted Expected Gross Premiums and                       
                Expected Future Benefit Payments (Details)                       
121: R102        Other Insurance Liabilities and Separate Accounts   HTML     55K  
                - Weighted-average Interest Rates and Durations                  
                (Details)                                                        
122: R103        Other Insurance Liabilities and Separate Accounts   HTML     67K  
                - Roll Forward of Policyholders' Funds (Details)                 
123: R104        Other Insurance Liabilities and Separate Accounts   HTML     81K  
                - Separate Account Assets (Details)                              
124: R105        Other Insurance Liabilities and Separate Accounts   HTML     63K  
                - Roll Forward of Separate Accounts (Details)                    
125: R106        Borrowings and Credit Agreements - Schedule of      HTML    201K  
                Borrowings (Details)                                             
126: R107        Borrowings and Credit Agreements - Debt Maturities  HTML     69K  
                (Details)                                                        
127: R108        Borrowings and Credit Agreements - Short-term       HTML     87K  
                Borrowings (Details)                                             
128: R109        Borrowings and Credit Agreements - Long-term        HTML    151K  
                Borrowings (Details)                                             
129: R110        Pension Plans and Other Postretirement Benefits -   HTML     74K  
                Narrative (Details)                                              
130: R111        Pension Plans and Other Postretirement Benefits -   HTML     92K  
                Benefit Obligations and Plan Assets (Details)                    
131: R112        Pension Plans and Other Postretirement Benefits -   HTML     59K  
                Net Periodic Benefit Cost (Income) (Details)                     
132: R113        Pension Plans and Other Postretirement Benefits -   HTML     52K  
                Weighted Average Assumptions Used (Details)                      
133: R114        Pension Plans and Other Postretirement Benefits -   HTML    172K  
                Fair Value of Pension Plan Assets (Details)                      
134: R115        Pension Plans and Other Postretirement Benefits -   HTML     60K  
                Changes in Level 3 Pension Plan Assets (Details)                 
135: R116        Pension Plans and Other Postretirement Benefits -   HTML     60K  
                Defined Benefit Plans Expected Benefit (Details)                 
136: R117        Income Taxes - Income Tax Provision (Details)       HTML     66K  
137: R118        Income Taxes - Effective Tax Rate Reconciliation    HTML     60K  
                (Details)                                                        
138: R119        Income Taxes - Deferred Tax Assets and Liabilities  HTML     84K  
                (Details)                                                        
139: R120        Income Taxes - Narrative (Details)                  HTML     53K  
140: R121        Income Taxes - Unrecognized Tax Benefits (Details)  HTML     57K  
141: R122        Stock Incentive Plans - Narrative (Details)         HTML    115K  
142: R123        Stock Incentive Plans - Stock-Based Compensation    HTML     56K  
                Expense (Details)                                                
143: R124        Stock Incentive Plans - Restricted Stock Unit and   HTML     75K  
                Performance Stock Unit Activity (Details)                        
144: R125        Stock Incentive Plans - Stock Option and SAR        HTML    123K  
                Activity (Details)                                               
145: R126        Stock Incentive Plans - Valuation Assumptions       HTML     69K  
                (Details)                                                        
146: R127        Shareholders' Equity - Share Repurchases (Details)  HTML     61K  
147: R128        Shareholders' Equity - Accelerated Share            HTML     78K  
                Repurchases (Details)                                            
148: R129        Shareholders' Equity - Dividends (Details)          HTML     50K  
149: R130        Shareholders' Equity - Regulatory Requirements      HTML     58K  
                (Details)                                                        
150: R131        Shareholders' Equity - Noncontrolling Interests     HTML     48K  
                (Details)                                                        
151: R132        Other Comprehensive Income (Loss) (Details)         HTML    121K  
152: R133        Earnings Per Share (Details)                        HTML     86K  
153: R134        Reinsurance - Narrative (Details)                   HTML     47K  
154: R135        Reinsurance - Reinsurance Recoverables (Details)    HTML     59K  
155: R136        Reinsurance - Effects of Reinsurance (Details)      HTML     65K  
156: R137        Commitments and Contingencies (Details)             HTML     77K  
157: R138        Segment Reporting - Narrative (Details)             HTML     54K  
158: R139        Segment Reporting - Retrospective Adjustments to    HTML     89K  
                Segment Composition (Details)                                    
159: R140        Segment Reporting - Reconciliation of Financial     HTML     92K  
                Measures of Segments to Consolidated Totals                      
                (Details)                                                        
160: R141        Segment Reporting - Reconciliation from Operating   HTML     74K  
                Income to Adjusted Operating Income (Details)                    
161: R9999       Uncategorized Items - cvs-20231231.htm              HTML     62K  
163: XML         IDEA XML File -- Filing Summary                      XML    302K  
166: XML         XBRL Instance -- cvs-20231231_htm                    XML   8.02M  
162: EXCEL       IDEA Workbook of Financial Report Info              XLSX    424K  
16: EX-101.CAL  XBRL Calculations -- cvs-20231231_cal                XML    590K 
17: EX-101.DEF  XBRL Definitions -- cvs-20231231_def                 XML   2.00M 
18: EX-101.LAB  XBRL Labels -- cvs-20231231_lab                      XML   4.37M 
19: EX-101.PRE  XBRL Presentations -- cvs-20231231_pre               XML   2.86M 
15: EX-101.SCH  XBRL Schema -- cvs-20231231                          XSD    426K 
164: JSON        XBRL Instance as JSON Data -- MetaLinks            1,093±  1.70M  
165: ZIP         XBRL Zipped Folder -- 0000064803-24-000007-xbrl      Zip   1.37M  


‘EX-32.1’   —   Certification — §906 – SOA’02


This Exhibit is an HTML Document rendered as filed.  [ Alternative Formats ]



 C:   C: 
  Document  

Exhibit 32.1
CERTIFICATION

The certification set forth below is being submitted in connection with the Annual Report of CVS Health Corporation (the "Company") on Form 10-K for the period ended December 31, 2023 (the “Report”) solely for the purpose of complying with Rule 13a-14(b) or Rule 15d-14(b) of the Securities Exchange Act of 1934 (the “Exchange Act”) and Section 1350 of Chapter 63 of Title 18 of the United States Code.
I, Karen S. Lynch, President and Chief Executive Officer of the Company, certify that, to the best of my knowledge:
1. the Report fully complies with the requirements of Section 13(a) or 15(d) of the Exchange Act; and
2. the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date:February 7, 2024
/S/    KAREN S. LYNCH
Karen S. Lynch
President and Chief Executive Officer



Dates Referenced Herein   and   Documents Incorporated by Reference

This ‘10-K’ Filing    Date    Other Filings
Filed on:2/7/248-K
For Period end:12/31/23
 List all Filings 


2 Subsequent Filings that Reference this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 5/08/24  CVS Health Corp.                  424B2                  2:528K                                   Donnelley … Solutions/FA
 5/07/24  CVS Health Corp.                  424B3                  1:490K                                   Donnelley … Solutions/FA


36 Previous Filings that this Filing References

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

11/01/23  CVS Health Corp.                  10-Q        9/30/23  103:18M
 8/02/23  CVS Health Corp.                  S-8         8/02/23    6:235K                                   Shearman & Sterling LLP
 8/02/23  CVS Health Corp.                  10-Q        6/30/23  104:18M
 6/02/23  CVS Health Corp.                  8-K:8,9     6/02/23   16:494K                                   Donnelley … Solutions/FA
 5/03/23  CVS Health Corp.                  10-Q        3/31/23  104:17M
 5/02/23  CVS Health Corp.                  S-8         5/02/23    5:247K                                   Shearman & Sterling LLP
 3/29/23  CVS Health Corp.                  S-8         3/29/23    5:195K                                   Shearman & Sterling LLP
 2/21/23  CVS Health Corp.                  8-K:8,9     2/21/23   15:416K                                   Donnelley … Solutions/FA
 2/08/23  CVS Health Corp.                  8-K:1,9     2/08/23   12:1.3M                                   Shearman & Sterling LLP
11/21/22  CVS Health Corp.                  8-K:5,8,9  11/17/22   11:425K                                   Shearman & Sterling LLP
 8/03/22  CVS Health Corp.                  10-Q        6/30/22   82:17M
 5/04/22  CVS Health Corp.                  10-Q        3/31/22   77:11M
 2/09/22  CVS Health Corp.                  10-K       12/31/21  137:25M
 8/18/21  CVS Health Corp.                  8-K:8,9     8/18/21   12:234K                                   Donnelley … Solutions/FA
 8/04/21  CVS Health Corp.                  10-Q        6/30/21   74:13M
 2/16/21  CVS Health Corp.                  10-K       12/31/20  137:25M
12/16/20  CVS Health Corp.                  8-K:8,9    12/16/20   13:293K                                   Donnelley … Solutions/FA
11/06/20  CVS Health Corp.                  10-Q        9/30/20   77:14M
 8/21/20  CVS Health Corp.                  8-K:8,9     8/21/20   14:446K                                   Donnelley … Solutions/FA
 5/19/20  CVS Health Corp.                  S-8         5/19/20    7:329K                                   Shearman & Sterling LLP
 3/31/20  CVS Health Corp.                  8-K:8,9     3/26/20   16:682K                                   Donnelley … Solutions/FA
 2/18/20  CVS Health Corp.                  10-K       12/31/19  147:29M
 8/15/19  CVS Health Corp.                  8-K:8,9     8/15/19   15:424K                                   Donnelley … Solutions/FA
 8/07/19  CVS Health Corp.                  10-Q        6/30/19   89:18M
 2/28/19  CVS Health Corp.                  10-K       12/31/18  142:25M
 6/05/18  CVS Health Corp.                  8-K:5,9     6/04/18    5:252K                                   Donnelley … Solutions/FA
 5/02/18  CVS Health Corp.                  10-Q        3/31/18   60:9M                                     Toppan Merrill Bridge/FA
 3/12/18  CVS Health Corp.                  8-K:8,9     3/06/18   12:771K                                   Donnelley … Solutions/FA
 8/08/17  CVS Health Corp.                  10-Q        6/30/17   57:8.8M                                   Toppan Merrill Bridge/FA
 2/09/17  CVS Health Corp.                  10-K       12/31/16  101:14M
 2/09/16  CVS Health Corp.                  10-K       12/31/15  102:14M
 2/10/15  CVS Health Corp.                  10-K       12/31/14   89:16M
 2/11/14  CVS Health Corp.                  10-K       12/31/13   91:15M
 8/04/09  CVS Health Corp.                  10-Q        6/30/09   29:2.2M                                   Donnelley … Solutions/FA
 8/15/06  CVS Health Corp.                  8-K:1,9     8/10/06    3:428K                                   Davis Polk & … LLP 01/FA
11/04/96  CVS Health Corp.                  8-B12B                 4:39K                                    Davis Polk & … LLP 01/FA
Top
Filing Submission 0000064803-24-000007   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Fri., May 10, 10:03:38.3am ET